Acquisition Candidate definition

Acquisition Candidate means any person or entity engaged in any of the businesses of distributing medical or healthcare products to hospitals, clinics, physicians, laboratories, pharmacies, alternate care sites or other medical or healthcare facilities or conceiving, designing, developing or testing technologically advanced medical or healthcare products, and (i) which was called on by the Company, in connection with the possible acquisition by the Company of that person or entity, or (ii) with respect to which the Company has made an acquisition analysis.
Sample 1Sample 2Sample 3
Acquisition Candidate means any person or entity engaged in the Business and (i) which was called on by the Company, in connection with the possible acquisition by the Company of that person or entity, or (ii) with respect to which the Company has made an acquisition analysis.
Sample 1Sample 2Sample 3
Acquisition Candidate means (I) any Person engaged in the Timeshare Business, or the purchase or development of real estate with the purpose of engaging in the Timeshare Business or (II) any project with respect to the Timeshare Business, and in either case (i) which was called on by Employer or its affiliates, in connection with the possible acquisition by Employer or its affiliates of that Person or project, or (ii) with respect which Employer or its affiliates has made an acquisition analysis.
Sample 1Sample 2Sample 3

Examples of Acquisition Candidate in a sentence

  • During the Restricted Period and thereafter for as long as the Executive shall remain an employee of or consultant to the Company, the Executive shall not call on any Acquisition Candidate (as defined below in this Section 4.1.6), with the knowledge of such Acquisition Candidate's status as such, for the purpose of acquiring, or arranging the acquisition of, that Acquisition Candidate by any person or entity other than the Company.

  • If the Company, Nationwide or a Nationwide Subsidiary makes an acquisition analysis of an entity as an Acquisition Candidate, but does not call upon such Acquisition Candidate, then such entity shall cease to be an Acquisition Candidate upon the expiration of 12 months after completion of the acquisition analysis; provided that nothing herein shall limit the covenants and agreements set forth above.

  • All acquisitions consummated by the Partnership using proceeds from this Offering will be limited to the RIA firms set forth on such RIA Firm Acquisition Candidate List.

  • During the Employment Term and the Restricted Period, the Executive shall not call on any Acquisition Candidate (as defined below in this Section 4.1.6), with the knowledge of such Acquisition Candidate's status as such, for the purpose of acquiring, or arranging the acquisition of, that Acquisition Candidate by any person or entity other than the Company.

  • All acquisitions consummated by the Partnership using such proceeds from the Offering will be limited to the RIA firms set forth on the RIA Firm Acquisition Candidate List.

  • In this Section 4.1.6 "Acquisition Candidate" means any person or entity engaged in the Business and (i) which was called on by the Company, in connection with the possible acquisition by the Company of that person or entity, or (ii) with respect to which the Company has made an acquisition analysis.

  • During the Employment Term and the Restricted Period, the Executive shall not call on any Acquisition Candidate (as defined below in this Section 4.1.6), with the knowledge of such Acquisition Candidate’s status as such, for the purpose of acquiring, or arranging the acquisition of, that Acquisition Candidate by any person or entity other than the Company.

  • Currently, we have identified 204 potential RIA firms, each of which is set forth on the RIA Firm Acquisition Candidate List beginning on page 5.

  • The principal purpose of this Offering is to make investments in certain private U.S. SEC RIA firms, primarily in the middle market, set forth on the RIA Firm Acquisition Candidate List starting on page 5 of this Offering Circular.

  • The principal purpose of this Offering is to make investments in certain private U.S. SEC RIA firms, primarily in the middle market, set forth on the RIA Firm Acquisition Candidate List on page 5 of this Offering Circular.


More Definitions of Acquisition Candidate

Acquisition Candidate means any person or entity engaged in any of the businesses of providing professional engineering services, and (i) which was called on by the Company, in connection with the possible acquisition by the Company of that person or entity, or (ii) with respect to which the Company has made an acquisition analysis.
Sample 1Sample 2Sample 3
Acquisition Candidate means (I) any Person engaged in the Timeshare Business, or the purchase or development of real estate with the purpose of engaging in the Timeshare Business or (II) any project with respect to the Timeshare Business, and in either case (i) which was called on by Employer or its affiliates, in connection with the possible acquisition by Employer or its affiliates of that Person or project, or (ii) with respect which Employer or its affiliates has made an acquisition analysis; or (iv) directly or indirectly employ, or knowingly permit any Person, directly or indirectly, controlled by him, to employ, any Person who was employed by Employer or its affiliates at or within the prior six months, or in any manner seek to induce any such Person to leave their employment.
Sample 1
Acquisition Candidate means a business that is a candidate for acquisition by the Company which Executive and the CEO have jointly identified and which the CEO has agreed to pursue, and which the Company requests that Executive assist it in any manner it may reasonably request within the parameters of this Agreement towards the execution of a non-binding letter of intent with that Acquisition Candidate and, if the Company determines to further pursue the Acquisition Candidate after signing a letter of intent, towards the execution of a definitive acquisition agreement relating to the Transaction. Each commission (a "Commission") which shall be paid to Executive after the closing of a Transaction involving an Acquisition Candidate pursuant to the first sentence of this Section 1.8 shall equal the sum of (i) two percent of that Acquisition Candidate's normalized earnings before interest, taxes, depreciation and amortization ("EBITDA") for the 12-month period ended on the most recent date for which financial statements are provided in the purchase agreement for that Acquisition Candidate (the "Acquisition Candidate's EBITDA") up to $5,000,000, plus (ii) one percent of that Acquisition Candidate's EBITDA, if any, in excess of $5,000,000. Each Commission earned by Executive pursuant to this Section 1.8 will be payable by the Company up to 100% in shares of common stock of the Company, $.001 par value ("Common Stock"), in the Company's sole discretion, and the remainder, if any, in cash. The number of shares of Common Stock delivered to Executive in connection with each Commission will be determined by using the average closing price of Common Stock as reported on the Nasdaq National Market for 10 consecutive trading days, with the last such trading day being the trading day that is three trading days prior to the closing date of the Transaction that generated that Commission. Notwithstanding anything to the contrary contained in this Section 1.8, the first $206,800 in aggregate Commissions will be offset by (and deemed earned in) Executive's annual base salary during the period from June 1, 2005 through May 31, 2006, and not paid to Executive, and any aggregate Commissions in excess of $206,800 will be paid to Executive. Any business that, as of June 1, 2005, is in active discussions with the Company, or has entered into a non-binding letter of intent with the Company, regarding a possible acquisition by the Company shall not be an Acquisition Candidate."
Sample 1
Acquisition Candidate means (1) any Person engaged in the business of purchasing, developing, marketing, selling and financing timeshare vacation intervals, or the purchase or development of real estate with the purpose of engaging in such business or (2) any project with respect to such business, and in either case (i) which was called on by Parent or its Affiliates, in connection with the possible acquisition by Parent or its Affiliates of that Person or project, or (ii) with respect which Parent or its Affiliates has made an acquisition analysis.
Sample 1
Acquisition Candidate is defined in Section 5.8.
Sample 1

Related to Acquisition Candidate

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • Product Candidate means each biological and drug candidate, compound or other device or product being developed, labeled, manufactured, marketed, sold and/or distributed by the Company or a Company Subsidiary, or regarding which the Company or a Company has rights, and including any such biological and drug candidate, compound or product that has received Marketing Approval.

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Target Acquisition means the Borrower’s acquisition of, directly or indirectly, all of the outstanding Capital Stock of the Target pursuant to a Scheme or Offer.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Acquisition Period means the period ending five (5) business days prior to

  • POC (Proof of Concept) means testing the Software for evaluation purposes.

  • Election campaign means any campaign in support of or in

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Transformative Acquisition means any acquisition or Investment by the Borrower or any Restricted Subsidiary that is either (a) not permitted by the terms of this Agreement immediately prior to the consummation of such acquisition or Investment or (b) if permitted by the terms of this Agreement immediately prior to the consummation of such acquisition or Investment, would not provide the Borrower and its Restricted Subsidiaries with adequate flexibility under this Agreement for the continuation and/or expansion of their combined operations following such consummation, as determined by the Borrower acting in good faith.

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Valid write-in candidate means a candidate who has qualified as a write-in

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Limited Condition Acquisition means any acquisition, including by way of merger, by the Borrower or one or more of its Restricted Subsidiaries permitted pursuant to this Agreement whose consummation is not conditioned upon the availability of, or on obtaining, third party financing.

  • Post-Acquisition Period means, with respect to any Permitted Acquisition, the period beginning on the date such Permitted Acquisition is consummated and ending on the last day of the sixth full consecutive fiscal quarter immediately following the date on which such Permitted Acquisition is consummated.

  • Parent Acquisition Proposal means any offer, proposal or indication of interest received from a third party (other than a party to this Agreement) providing for any Parent Acquisition Transaction.

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Qualifying Acquisition has the meaning specified in Section 5.03.

  • Development Milestone is defined in Section 5.3.